Profile
Ms. Darlene Noci was previously employed as a Chief Development Officer by Nuvalent, Inc., a Founder by Noci Strategic Consulting LLC, a VP-Regulatory Affairs & Quality Assurance by X4 Pharmaceuticals, Inc., a Principal by EMD Serono, Inc., and a Head-Regulatory Affairs by AVEO Pharmaceuticals, Inc. She received her undergraduate degree from Adelphi University and a graduate degree from Harvard University.
Former positions of Darlene Noci
| Companies | Position | End |
|---|---|---|
| NUVALENT, INC. | General Counsel | 20/07/2022 |
| X4 PHARMACEUTICALS, INC. | General Counsel | 01/05/2018 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/01/2016 |
Noci Strategic Consulting LLC | Founder | - |
| AVEO PHARMACEUTICALS, INC. | General Counsel | - |
Training of Darlene Noci
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adelphi University
Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Noci Strategic Consulting LLC |
- Stock Market
- Insiders
- Darlene Noci
















